Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
XpresSpa signs contract with JFK International Air Terminal for COVID-19 testing » 09:07
05/22/20
05/22
09:07
05/22/20
09:07
XSPA

XpresSpa

$0.52 /

+0.04 (+8.42%)

XpresSpa Group provided a…

XpresSpa Group provided a business update related to its objective of pursuing COVID-19 screening and testing in convenient and accessible locations at U.S. airports. The Company is pleased to announce that it has signed a contract with JFK International Air Terminal to pilot test its concept of providing diagnostic COVID-19 tests located in Terminal 4. To facilitate the JFK pilot test, the Company has signed an agreement with JFKIAT for a new modular constructed testing facility within the terminal. The site will host nine separate testing rooms with a capacity to administer over 500 tests per day. The Company intends to offer its services to airline employees, contractors and workers, concessionaires and their employees, TSA officers, and U.S. Customs and Border Protection agents. All COVID-19 screening and testing will be conducted by a newly launched brand, XpresCheck, which will operate under the Company's XpresTest subsidiary. The Company is also working closely with the Port Authority of New York and New Jersey to bring XpresCheck locations to other locations. A formal announcement with additional details is expected to be made in the coming weeks in conjunction with the Port Authority of New York and New Jersey and JFKIAT. In addition, the Company is in discussions with other U.S. airports regarding the temporary conversions of existing XpresSpa locations into XpresCheck testing sites as it looks to roll out this concept further. The Company also announced the launch of XpresCheck, the operating brand under which the Company's previously formed XpresTest subsidiary will screen and test for COVID-19. Although the JFK pilot test site will be in a newly constructed modular facility, the Company is discussing temporary conversions of existing XpresSpa locations into XpresCheck testing sites as it looks to roll out this concept to other U.S. airports.

ShowHide Related Items >><<
XSPA XpresSpa
$0.52 /

+0.04 (+8.42%)

Over a month ago
Hot Stocks
XpresSpa pursues COVID-19 screening,testing at U.S. airports » 15:14
04/03/20
04/03
15:14
04/03/20
15:14
XSPA

XpresSpa

$0.22 /

+0.0536 (+33.00%)

XpresSpa Group provided…

XpresSpa Group provided an update on recent discussions with local airport authorities and healthcare partners so that it may begin providing screening and testing for novel coronavirus at U.S. airports. COVID-19 screening and testing would be conducted by converting select existing spa locations for this purpose on an interim basis and over time, potentially adding separate, standalone airport locations as testing sites. XpresSpa's U.S. airport real estate portfolio consists of 46 locations across 23 airports that are ready to be reactivated and redeployed in short order, subject to the approval of local airport authorities. The company's global spas are temporarily closed due to recent local government mandates categorizing its traditional services as "non-essential services." Since March 19, XpresSpa has been advancing discussions with healthcare partners to develop a model for COVID-19 screening and testing in U.S. airports as a much-needed public service. The company has also recently filed paperwork in the State of Delaware to form a new business unit to administer such screening and testing capabilities, XpresTest, as a wholly-owned subsidiary of XpresSpa Group. While nothing definitive has yet been finalized, XpresSpa is currently in discussions with three major airports, JFK, Hartsfield-Jackson Atlanta, and Chicago O'Hare to pilot COVID-19 screening and testing for airline employees, contractors and workers, concessionaires and their employees, TSA agents, and U.S. Customs and Border Protection agents. The company is also in the process of recruiting a medical director who would work alongside healthcare officials to help design safe and compliant protocols and train employees.

Hot Stocks
XpresSpa pursues COVID-19 screening, testing at U.S. airports » 09:22
04/03/20
04/03
09:22
04/03/20
09:22
XSPA

XpresSpa

$0.16 /

-0.0176 (-9.78%)

, DGX

Quest Diagnostics

$77.47 /

-1.16 (-1.48%)

, AYTU

Aytu BioScience

$1.56 /

+0.035 (+2.30%)

, HSIC

Henry Schein

$48.44 /

-0.16 (-0.33%)

XpresSpa Group (XSPA)…

XpresSpa Group (XSPA) provided an update on recent discussions with local airport authorities and healthcare partners so that it may begin providing screening and testing for novel coronavirus at U.S. airports. COVID-19 screening and testing would be conducted by converting select existing spa locations for this purpose on an interim basis and over time, potentially adding separate, standalone airport locations as testing sites. XpresSpa's U.S. airport real estate portfolio consists of 46 locations across 23 airports that are ready to be reactivated and redeployed in short order, subject to the approval of local airport authorities. The Company's global spas are temporarily closed due to recent local government mandates categorizing its traditional services as "non-essential services". Since March 19, 2020, XpresSpa has been advancing discussions with healthcare partners to develop a model for COVID-19 screening and testing in U.S. airports as a much-needed public service. The Company has also recently filed paperwork in the State of Delaware to form a new business unit to administer such screening and testing capabilities, XpresTest, Inc., as a wholly-owned subsidiary of XpresSpa Group, Inc. While nothing definitive has yet been finalized, XpresSpa is currently in discussions with three major airports, JFK International Airport, Hartsfield-Jackson Atlanta International Airport and Chicago O'Hare International Airport to pilot COVID-19 screening and testing for airline employees, contractors and workers, concessionaires and their employees, TSA agents, and U.S. Customs and Border Protection agents. The Company is also in the process of recruiting a medical director who would work alongside healthcare officials to help design safe and compliant protocols and train employees. The Company recently announced its partnership with Relevant Healthcare. Relevant Healthcare is currently offering clinical diagnostic testing for COVID-19 through its contracts with Laboratory Corporation of America and Quest Diagnostics (DGX) to support full COVID-19 RT-PCR testing. In addition, the Company is also in active discussions with Aytu Biosciences (AYTU), a marketer of a COVID-19 IgG/IgM Rapid Test, and Henry Schein Medical (HSIC), the developer of the Standard Q COVID-19 test, to deploy their respective rapid antibody blood testing solutions. XpresSpa would also partner with Healthalytica. Healthalytica would be charged with processing claims, insurance payments and distributing test result data to the appropriate local, state, and national authorities.

ShowHide Related Items >><<
XSPA XpresSpa
$0.16 /

-0.0176 (-9.78%)

DGX Quest Diagnostics
$77.47 /

-1.16 (-1.48%)

03/30/20 Wells Fargo
Quest Diagnostics price target lowered to $80 from $100 at Wells Fargo
03/27/20
Fly Intel: Top five analyst downgrades
03/27/20 Morgan Stanley
Morgan Stanley cuts Quest, upgrades Charles River in Healthcare Service shake-up
03/27/20 Morgan Stanley
Quest Diagnostics downgraded to Equal Weight from Overweight at Morgan Stanley
AYTU Aytu BioScience
$1.56 /

+0.035 (+2.30%)

09/18/19 Ladenburg
Aytu BioScience price target raised to $4.75 from $4.00 at Ladenburg
HSIC Henry Schein
$48.44 /

-0.16 (-0.33%)

04/02/20 Wolfe Research
Henry Schein upgraded to Outperform from Peer Perform at Wolfe Research
02/07/20 Cleveland Research
Large dental manufacturer seen exploring direct move, says Cleveland Research
01/09/20 BofA
Henry Schein downgraded to Underperform from Neutral at BofA
01/09/20 BofA
Henry Schein downgraded to Underperform from Neutral at BofA
Hot Stocks
XpresSpa announces partnership with Relevant Healthcare » 09:17
03/25/20
03/25
09:17
03/25/20
09:17
XSPA

XpresSpa

$0.14 /

+0.0036 (+2.57%)

XpresSpa Group announced…

XpresSpa Group announced an update to discussions in converting its spa locations into novel coronavirus testing locations. XpresSpa will be partnering with Relevant Healthcare Cost Containment, the registered trade name of Contain Holdings, LLC, an Illinois limited liability company, a Chicago-area healthcare cost containment, payment integrity and transparency company. Relevant Healthcare had previously announced that it is offering testing for COVID-19 through its contracts with both Laboratory Corporation of America and Quest Diagnostics. Both LabCorp and Quest are the leading laboratory companies in the U.S. and have the current capacity to process tens of thousands of COVID-19 tests per day. All COVID-19 testing will be done by appropriately licensed health professionals in accordance with applicable federal and state laws. The company said, "With our global spas temporarily closing due to recent local government mandates categorizing our traditional services as "non-essential services", XpresSpa is actively advancing conversations with COVID-19 testing partners to develop a model for testing in U.S. airports including point of entry cities such as New York, Los Angeles, San Francisco, Chicago, Miami, Atlanta and Washington D.C. We have had dialog with the offices of U.S. Senators, Governors, federal authorities and other various agencies to assist in the effort to expedite COVID-19 testing as a much-needed public service. Our airport real estate portfolio of 46 locations across 23 U.S. airports is ready to reactivate and be redeployed in partnership with local airport authorities in short order."

Hot Stocks
XpresSpa seeks to support COVID-19 testing in 46 locations across 23 airports » 09:52
03/19/20
03/19
09:52
03/19/20
09:52
XSPA

XpresSpa

$0.19 /

+0.0243 (+14.67%)

XpresSpa Group announced…

XpresSpa Group announced that it has reached out to multiple government agencies, including the Centers for Disease Control and Prevention and the U.S. Department of Health and Human Services, as well as private laboratories across the country. The company said it has engaged in early high-level discussions with regards to turning all of its 46 airport locations, with many, located in point of entry cities, such as New York, Los Angeles, San Francisco, Chicago, Miami, Atlanta, and Washington DC into COVID-19 testing facilities. The company believes that its spas offer a range of spaces that can be set up to test airport staff, flight crews, and passengers. Doug Satzman, XpresSpa, Chief Executive Officer, said, "We believe we can we help alleviate some of the long waits for travelers entering the US but we can also be available to test TSA employees, pilots, Flight Attendants and other airport personnel who are on the front lines helping to keep our nation safe."

Over a quarter ago
Hot Stocks
XpresSpa announces strategic partnership with Sanctifly » 09:19
03/02/20
03/02
09:19
03/02/20
09:19
XSPA

XpresSpa

$0.82 /

+0.12 (+17.14%)

XpresSpa Group announced…

XpresSpa Group announced the Company has secured a partnership with Sanctifly that will launch on March 15, 2020. Sanctifly is a fast growing subscription-based app which provides its frequent flying members with access to a global network of health and wellness facilities in and around airports. Under the terms of the agreement, XpresSpa will be one of the largest corporate partners at which Sanctify subscribers can use $30 vouchers towards spa services at any domestic XpresSpa location.

Hot Stocks
XpresSpa sees FY19 domestic comparable store sales up 4.2% » 07:27
01/14/20
01/14
07:27
01/14/20
07:27
XSPA

XpresSpa

$0.60 /

+0.0059 (+1.00%)

Doug Satzman,…

Doug Satzman, XpresSpa's CEO, stated, "Our preliminary results for domestic comparable store sales demonstrate strong progress in our business turnaround and exemplify our positioning as the health and wellness destination for the modern traveler. During the fourth quarter, we took full advantage of the busy holiday season by servicing our clients with exceptional spa treatments while providing them with a vast array of relevant in-spa products for purchase, including our expanded Calm retail collection and new Persona vitamin products. In fact, domestic comparable store sales for December rose a promising 10.2%, our best month since January 2017. We are thrilled to have opened our fourth spa in Hartsfield-Jackson Atlanta International Airport, where we already have considerable brand awareness and a loyal guest following. As the nation's busiest airport by passengers served, the Atlanta market is strategically important to XpresSpa and we are therefore excited that we can now delight guests with our health and wellness services and exclusive luxury travel products and accessories across spas in Concourses A, C, D, and E. Our portfolio optimization continues as we closed two tertiary spas in JFK International Airport at the end of December which had a negative contribution to our operations. We only have one more low sales volume spa targeted for an out-of-cycle spa closure in spring 2020, which will complete the systematic pruning of underperforming locations that I identified when joining the business almost one year ago. We are also looking to the future and therefore plan to open several spas in 2020 within successful, existing markets along with new markets, particularly internationally, where we already operate some of our most profitable locations. Lastly, we intend to build on what we have already accomplished by extending our comparable store sales momentum, improving four-wall margins and managing G&A through effective cost management at the store and corporate level. We also intend to forge new strategic partnerships with brands that share our commitment to health and wellness and can further monetize our desirable real estate and affluent customer base."

ShowHide Related Items >><<
Hot Stocks
XpresSpa sees Q4 domestic comparable store sales up 7.7% » 07:26
01/14/20
01/14
07:26
01/14/20
07:26
XSPA

XpresSpa

$0.60 /

+0.0059 (+1.00%)

December domestic…

December domestic comparable store sales increased 10.2%, representing the best monthly result since January 2017.

ShowHide Related Items >><<
Hot Stocks
XpresSpa says strategic partnerships 'well positioned' for holiday travel season » 09:19
12/17/19
12/17
09:19
12/17/19
09:19
XSPA

XpresSpa

$0.61 /

+0.019 (+3.21%)

XpresSpa Group provided…

XpresSpa Group provided the following business update regarding its strategic partnerships that are well-positioned to produce results during the record holiday travel season. The company said,"Our Calm retail collection has been expanded to include a new weighted travel blanket complementing the Calm weighted sleep mask that launched last month, both of which both promote faster and deeper sleep. These new Calm-branded products were designed in collaboration with industry leader Gravity. Persona products are now available across all domestic airport spas. Persona is a Nestle Health Science company and leading personalized vitamin-subscription program that signed a strategic partnership agreement with XpresSpa in late October. Customers can purchase three different nutrition packs in every spa designed especially for travelers to support relaxation, immunity or jet lag, while additionally receiving an exclusive discount for XpresSpa customers on their first online order. We are launching a seven-week CBD test pilot across 16 domestic airport stores this week featuring three products from Nira. Nira is an emerging brand and a producer of physician-formulated CBD products that are produced with the highest quality hemp extract. The three products that are currently being tested are a hemp oil lotion, full spectrum soft gel capsules, and a full spectrum tincture oil."

Hot Stocks
XpresSpa announces renewed partnership with Hartsfield-Jackson airport » 09:04
12/05/19
12/05
09:04
12/05/19
09:04
XSPA

XpresSpa

$0.68 /

-0.0134 (-1.93%)

XpresSpa Group, Cordial…

XpresSpa Group, Cordial Endeavor Concessions of Atlanta, and the City of Atlanta, together announced that the Atlanta City Council has approved new five-year terms for XpresSpa's leases on two of its busiest concourses at the Hartsfield-Jackson Atlanta International Airport, Concourses A and C. The new lease terms facilitate the Settlement Agreement among these parties, pursuant to which XpresSpa has agreed to resume its joint venture with Cordial Endeavor Concessions of Atlanta. This agreement brings to a close six years of mediation, Federal Aviation Administration proceedings and litigation. The FAA is in agreement with the Settlement Agreement, and the parties involved will seek dismissal of all pending litigation.

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.